Literature DB >> 8922251

Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta.

R Kruse1, M Merten, K Yoshida, A Schmidt, W Völker, E Buddecke.   

Abstract

Glycosaminoglycans are regular constituents of the arterial wall and essential for its structure and function. The arteriosclerosis-dependent changes of glycosaminoglycans were investigated, the degree of arteriosclerosis was monitored by the cholesterol content of the tissue. Histological characterization was achieved by electron microscopy. Total glycosaminoglycans were isolated from 33 delipidated segments of human aorta thoracica after exhaustive proteolytic digestion, and fractionated into the individual glycosaminoglycans by a multistep purification procedure. Chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate (HS), and hyaluronate (HA) were identified and quantified by chemical and enzymatic analysis. The concentration of total and individual glycosaminoglycans, expressed as mg/g delipidated dry weight of tissue, decreased significantly with increasing cholesterol content of tissue (p = 0.0005-0.005). The extent of decrease differed between the individual glycosaminoglycans as indicated by a shift in the CS/DS:HA:HS ratio from 47:32:21 in low cholesterol aortic segments to 59:29:12 in cholesterol-rich specimens. Determination of the relative molecular masses (Mr) revealed 58 kDa for CS/DS and 92 kDa for HS with a (statistically not significant) increase of the molecular mass of CS/DS and a decrease of HS with increasing cholesterol content. The copolymeric CS/DS glycosaminoglycans were disintegrated enzymatically into CS and DS containing fragments. A significantly higher relative DS content (p = 0.01) was found in cholesterol-rich arterial tissue (32.5%) as compared with low cholesterol tissue samples (28.8%). Cell culture experiments revealed that human arterial HS is able to inhibit the proliferation of cultured human arterial smooth muscle cells. The HS concentration required for a 30% inhibition of smooth muscle cell proliferation was in the same order as the tissue concentration of HS. This confirms the function of HS as an endogenous inhibitor of cell division and its impact for the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922251     DOI: 10.1007/bf00788713

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  42 in total

Review 1.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

2.  Glycosaminoglycans in normal and atherosclerotic human coronary arteries.

Authors:  S Ylä-Herttuala; H Sumuvuori; K Karkola; M Möttönen; T Nikkari
Journal:  Lab Invest       Date:  1986-04       Impact factor: 5.662

3.  Growth status-dependent changes of bFGF compartmentalization and heparan sulfate structure in arterial smooth muscle cells.

Authors:  A Schmidt; A Skaletz-Rorowski; G Breithardt; E Buddecke
Journal:  Eur J Cell Biol       Date:  1995-06       Impact factor: 4.492

4.  Cytochemical changes in a human arterial proteoglycan related to atherosclerosis.

Authors:  W Völker; A Schmidt; E Buddecke
Journal:  Atherosclerosis       Date:  1989-06       Impact factor: 5.162

5.  The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-O-sulfated uronic acid residues.

Authors:  A Schmidt; K Yoshida; E Buddecke
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

6.  Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries.

Authors:  R Riessen; J M Isner; E Blessing; C Loushin; S Nikol; T N Wight
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

7.  Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL.

Authors:  L E Cardoso; P A Mourão
Journal:  Arterioscler Thromb       Date:  1994-01

8.  Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.

Authors:  P Bendayan; H Boccalon; D Dupouy; B Boneu
Journal:  Thromb Haemost       Date:  1994-05       Impact factor: 5.249

9.  Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry.

Authors:  L Y Yao; C Moody; E Schönherr; T N Wight; L J Sandell
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

10.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.

Authors:  J A Marcum; D H Atha; L M Fritze; P Nawroth; D Stern; R D Rosenberg
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

View more
  3 in total

Review 1.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

Review 2.  DAMPening inflammation by modulating TLR signalling.

Authors:  A M Piccinini; K S Midwood
Journal:  Mediators Inflamm       Date:  2010-07-13       Impact factor: 4.711

3.  A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome.

Authors:  Stephanie Seneff; Robert M Davidson; Ann Lauritzen; Anthony Samsel; Glyn Wainwright
Journal:  Theor Biol Med Model       Date:  2015-05-27       Impact factor: 2.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.